ANIXIKE Numbing

Manufacturer
Jiangxi Hemei Pharmaceutical Co., Ltd
Effective date
2025-07-08
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-01 20:36:00

Label at a glance#

ProductANIXIKE Numbing
Active ingredientLIDOCAINE
Label structure13 sections

Dosage and administration

■Before applying the numbing cream,make sure to wash your hands thoroughly and put ondisposable procedure gloves. ■Clean the area of the body receivina the procedure. Dry completely ■Apply athin layer of cream to the affected area and rub it in thoroughly in a circular motionfor 30 to 60 seconds.Do not use more than 3 to 4 times daily. Do not apply over large areas of the body. ■Leave the cream and wrap in place f...

Storage and handling

■Store between 15-30 C(59-86°F).Avoid freezing and excessive heat above 40°C(104F) ■Storage and Handling

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Lidocaine 4%

Purpose

OTC - PURPOSE SECTION

Local Anesthetic

Use

INDICATIONS & USAGE SECTION

For temporary relief of local discomfort, itching, pain, soreness,or burning associated with minor skin procedure

Warnings

WARNINGS SECTION

■For external use only.

■Do not use with a bandage or cover the treated area tightly unless directed by a doctor.
■ Ask a doctor before use for children under 12 years of age.

Do not use

OTC - DO NOT USE SECTION

■Do not use with a bandage or cover the treated area tightly unless directed by a doctor

When Using

OTC - WHEN USING SECTION

■ -Avoid contact with eyes, If this happens, rinse thoroughly with water.

■ -If symptoms persist for more than 7 days or subside but occur again within 3 days, stop useand consult a physician.

Stop Use

OTC - STOP USE SECTION

■Meditcal attention if signs of an alerqy occur,such as rednes,irtation,sweling, pain, or other severe symptoms.If symptoms do not subside completely within 7 days, seek medical help.

Ask Doctor

OTC - ASK DOCTOR SECTION

■Meditcal attention if signs of an alerqy occur,such as rednes,irtation,sweling, pain, or other severe symptoms.If symptoms do not subside completely within 7 days, seek medical help.

■ Ask a doctor before use for children under 12 years of age.

■ -If symptoms persist for more than 7 days or subside but occur again within 3 days, stop useand consult a physician.

Keep Out Of Reach Of Children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children

Directions

DOSAGE & ADMINISTRATION SECTION

■Before applying the numbing cream,make sure to wash your hands thoroughly and put ondisposable procedure gloves.

■Clean the area of the body receivina the procedure. Dry completely

■Apply athin layer of cream to the affected area and rub it in thoroughly in a circular motionfor 30 to 60 seconds.Do not use more than 3 to 4 times daily. Do not apply over large areas of the body.

■Leave the cream and wrap in place for 30 to 45 minutes. Wipe away the cream and thoroughly clean the area to prepare for the upcoming procedure.

Other information

STORAGE AND HANDLING SECTION

■Store between 15-30 C(59-86°F).Avoid freezing and excessive heat above 40°C(104F)

■Storage and Handling

Inactive ingredients

INACTIVE INGREDIENT SECTION

■Water ,Carbomer 934,Propylene Glycol,Soybean Lecithin,.Alpha.-Tocopherol Acetate,Benzyl Alcohol.

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

11

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
84010-14884010-148-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
4a4c792c-ebce-db4a-e063-6394a90ae4a23977b7ce-ce74-5203-e063-6394a90ac7152026-02-08WarningsExact identifier
spl set id: 3977b7ce-ce74-5203-e063-6394a90ac715

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.